Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potential RNA-dependent RNA polymerase (RdRp) inhibitors as prospective drug candidates for SARS-CoV-2
Mohamed S. Bekheit, Siva S. Panda, Adel S. Girgis
European Journal of Medicinal Chemistry (2023) Vol. 252, pp. 115292-115292
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Design, synthesis, and biological evaluation of first-in-class indomethacin-based PROTACs degrading SARS-CoV-2 main protease and with broad-spectrum antiviral activity
Jenny Desantis, Alessandro Bazzacco, Michela Eleuteri, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116202-116202
Open Access | Times Cited: 10
The Chiral 5,6-Cyclohexane-fused Uracil Ring-System: a Molecular Platform with Promising Activity against SARS-CoV-2
Enrico Marcantonio, Debora Guazzetti, Crescenzo Coppa, et al.
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117302-117302
Closed Access | Times Cited: 1
Synergism between remdesivir and ribavirin leads to SARS‐CoV‐2 extinction in cell culture
Carlos García‐Crespo, Ana Isabel de Ávila, Isabel Gallego, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 15, pp. 2636-2654
Open Access | Times Cited: 6
Nucleoside antiviral agents with atypical structures and new targets
Hui Xu, B. Li, Kai Tang, et al.
Bioorganic & Medicinal Chemistry Letters (2025) Vol. 119, pp. 130110-130110
Closed Access
Structural basis of SARS-CoV-2 polymerase inhibition by nonnucleoside inhibitor HeE1-2Tyr
Florian Kabinger, Valerie Doze, Jana Schmitzová, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 10
Open Access
Development of Fluorescence-Based Assays for Key Viral Proteins in the SARS-CoV-2 Infection Process and Lifecycle
Mingzhenlong Deng, Chuang Zhang, Wanli Yan, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2850-2850
Open Access | Times Cited: 4
Indole-Based Compounds as Potential Drug Candidates for SARS-CoV-2
Adel S. Girgis, Siva S. Panda, Benson M. Kariuki, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6603-6603
Open Access | Times Cited: 10
Main and papain-like proteases as prospective targets for pharmacological treatment of coronavirus SARS-CoV-2
Larysa V. Yevsieieva, Kateryna Lohachova, Alexander Kyrychenko, et al.
RSC Advances (2023) Vol. 13, Iss. 50, pp. 35500-35524
Open Access | Times Cited: 10
Recent advancements in the discovery of small-molecule non-nucleoside inhibitors targeting SARS-CoV-2 RdRp
Bangdi Zhou, D. Chen, Tingyan Zhang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116180-116180
Open Access | Times Cited: 3
Indole Compounds in Oncology: Therapeutic Potential and Mechanistic Insights
S. M. E. HASSAN, Alyaa Farid, Siva S. Panda, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 922-922
Open Access | Times Cited: 3
Assessing the Potential Contribution of In Silico Studies in Discovering Drug Candidates That Interact with Various SARS-CoV-2 Receptors
Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonkululeko Avril Mbatha, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15518-15518
Open Access | Times Cited: 7
Novel analogues of a nonnucleoside SARS-CoV-2 RdRp inhibitor as potential antivirotics
L Tóth, Kateřina Krejčová, Milan Dejmek, et al.
Beilstein Journal of Organic Chemistry (2024) Vol. 20, pp. 1029-1036
Open Access | Times Cited: 2
Indole-based compounds as potential drug candidates for SARS-CoV-2
Adel S. Girgis, Siva S. Panda, Benson M. Kariuki, et al.
(2023)
Open Access | Times Cited: 6
How many organic small molecules might be used to treat COVID-19? From natural products to synthetic agents
Zai‐Qun Liu
European Journal of Medicinal Chemistry (2024) Vol. 278, pp. 116788-116788
Closed Access | Times Cited: 1
In Silico Evaluation of Favipiravir-associated Potential New Drugs against Polymerase Enzyme of SARS-CoV-2
Saira, Khalid Ali Khan, Asaduzzaman Khan, et al.
Heliyon (2024) Vol. 10, Iss. 19, pp. e38479-e38479
Open Access | Times Cited: 1
Combating Emerging Respiratory Viruses: Lessons and Future Antiviral Strategies
Palaniyandi Muthukutty, Jaime MacDonald, So Young Yoo
Vaccines (2024) Vol. 12, Iss. 11, pp. 1220-1220
Open Access | Times Cited: 1
Perspective for Drug Discovery Targeting SARS Coronavirus Methyltransferases: Function, Structure and Inhibition
Xin Li, Yongcheng Song
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 21, pp. 18642-18655
Closed Access | Times Cited: 1
A Cell-Penetrating NS5B-Specific Nanobody Inhibits Bovine Viral Diarrhea Virus Replication
Zhiqian Ma, Zhiwei Li, Ting Yang, et al.
Microbial Pathogenesis (2024) Vol. 197, pp. 107107-107107
Closed Access | Times Cited: 1
How Much Potential Do Nucleoside Analogs Offer to Combat Human Corona Viruses?
Włodzimierz Buchowicz, Mariola Koszytkowska‐Stawińska
Organics (2024) Vol. 5, Iss. 2, pp. 71-110
Open Access
In silico Exploration of Inhibition Mechanism of Lianhua Qingwen Formula (LQF) Interaction on SARS-CoV-2 Mpro
Xiaolong Xue, Xin Wang, Chenghao Ye, et al.
Chemical Research in Chinese Universities (2024)
Closed Access
Amplification‐free sub-femtomolar monitoring of SARS-CoV-2-RNA in serum samples using cDNA-modified MoS2 field-effect transistor
Fatemeh Mirzapour, Mojtaba Shamsipur, Kimia Ahanjan, et al.
Microchemical Journal (2024), pp. 111955-111955
Closed Access
Interference of small compounds and Mg2+ with dsRNA-binding fluorophores compromises the identification of SARS-CoV-2 RdRp inhibitors
Susana Llanos, Bruno Di Geronimo, Ester Casajús, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Covalent DNA-Encoded Library Workflow Drives Discovery of SARS-CoV-2 Nonstructural Protein Inhibitors
Xudong Wang, Liwei Xiong, Ying Zhu, et al.
Journal of the American Chemical Society (2024)
Closed Access
Efficient in vitro assay for evaluating drug efficacy and synergy against emerging SARS-CoV-2 strains
Maximillian Woodall, Samuel Ellis, Shengyuan Zhang, et al.
Antimicrobial Agents and Chemotherapy (2024)
Open Access
Lycorine esters exert anti-HCoV-OC43 effect through reversibly acylating cysteine residue in the nsp 12 NiRAN domain
Yuheng Mei, Zhihui Yu, Yue Gong, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 108086-108086
Closed Access
Page 1 - Next Page

Scroll to top